What’s New at APS BioGroup

APS BioGroup Announces Completion of Facility Expansion and Enhanced Capabilities

Bob Davies (President and CEO) said: "With completion of this expansion our capabilities to grow and serve our customers are significantly enhanced. Our colostrum plant processing capacity has been increased by 50%, our contract manufacturing capacity has been increased by 75% and we have hired five additional college graduate scientists in our laboratory to increase our in-house testing and compliance capabilities."